Immunic Phase 3 MS study advances following positive recommendation from independent committee
ImmunicImmunic(US:IMUX) Proactiveinvestors NA·2024-10-22 13:16

Group 1 - The company specializes in medium and small-cap markets while also providing updates on blue-chip companies, commodities, and broader investment stories [2] - Proactive delivers news and unique insights across various sectors including biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [2] - The company has a strong focus on technology adoption, utilizing automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [2] Group 2 - Proactive's news team operates from key finance and investing hubs globally, including London, New York, Toronto, Vancouver, Sydney, and Perth [1] - The company aims to provide fast, accessible, informative, and actionable business and finance news content to a global investment audience [1] - Proactive's content is produced independently by experienced and qualified teams of news journalists [1]

Immunic Phase 3 MS study advances following positive recommendation from independent committee - Reportify